Copying Valeant’s Xifaxan just got ‘a lot easier,’ thanks to new FDA guidance: analyst chelfand Tue, 03/21/2017 – 11:07 More: Copying Valeant's Xifaxan just got 'a lot easier,' thanks to new FDA guidance: analyst Source: fierce
read moreThe government has launched a consultation on new proposals to expand protection for NHS whistleblowers. More: Gov’t plans to expand protection for NHS whistleblowers Source: News
read moreLondon, UK-based healthcare and life science group Arix Bioscience has signed an agreement with the Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MPI), and the University of Leeds to develop new therapeutics for metabolic diseases based on the
read moreNovartis has unveiled trial results which it says show that Cosentyx is the first and only IL-17A inhibitor to potentially modify the course of psoriasis. More: Study shows Novartis’ Cosentyx may modify course of psoriasis Source: News
read moreAn experimental breast cancer combination being developed by Eli Lilly has hit its key goal of extending progression-free survival (PFS) in certain patients with advanced disease. More: Come-back for Lilly’s breast cancer drug Source: News
read moreGlaxoSmithKline More: GSK’s MUSCA study shows Nucala (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype Source: MDlinx
read more© 1994 - 2026 B.M. Pharmaceuticals